Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Dr. Falk Pharma GmbH
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Signed informed consent,
Male or female patients, 18 to 75 years of age,
Confirmed clinico-pathological diagnosis of eosinophilic esophagitis (EoE) according to established diagnostic criteria
Active symptomatic and histological EoE
Negative pregnancy test in females of childbearing potential at baseline visit.
You may not be if
Clinical and endoscopic signs of gastroesophageal reflux disease (GERD),
Achalasia, scleroderma esophagus, or systemic sclerosis,
Other clinically evident causes than EoE for esophageal eosinophilia,
Any concomitant esophageal disease and relevant gastro-intestinal disease (celiac disease, inflammatory bowel disease, oropharyngeal or esophageal bacterial, viral, or fungal infection \[candida esophagitis\]),
Any relevant systemic disease (e.g., AIDS, active tuberculosis, hepatitis B or C),
If careful medical monitoring is not ensured: cardiovascular disease, diabetes mellitus, osteoporosis, active peptic ulcer disease, glaucoma, cataract, or infection,
Liver cirrhosis or portal hypertension,
History of cancer in the last five years,
History of esophageal surgery at any time or of esophageal dilation procedures within the last 4 weeks prior to screening visit, or need for an immediate endoscopic intervention due to a stricture
Upper gastrointestinal bleeding within 8 weeks prior to baseline visit,
Existing or intended pregnancy or breast-feeding.
Clareo Health | Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
